Initial Quarterly Notice Report by Institutional Manager - Form 13F-NT
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
09/14/2023 | Press release | Distributed by Public on 09/14/2023 06:02
Please select the service you want to use:
Smartlinks | Colombier Acquisition Corp. | Company News | Top Company News | Shareholder Meeting | Financial Services | Investment Funds | Lifestyle and Leisure | Leisure | Securities Issuers | Shell Companies | New York Stock Exchange (NYSE) | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact